Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Clinical trial NCT05147467 · RECRUITING

Trial details

NCT number: NCT05147467
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2021-12-28
Primary completion: 2026-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.